Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion.
Camille Le GallAnna CammarataLukas de HaasIván Ramos-TomilleroJorge Cuenca-EscalonaKayleigh SchourenZacharias WijfjesAnouk M D BeckerJohanna BödderYusuf DölenIngrid Jolanda M De VriesCarl G FigdorGeorgina Flórez-GrauMartijn VerdoesPublished in: Journal for immunotherapy of cancer (2022)
T cell responses.